Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenzo Oba

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Lipids in Health and Disease|March 19, 2013
Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: Lp(a) phenotype, lymphocyte, and coronary heart diseaseTatsuya Suzuki, Shoko Futami-Suda, Yoshimasa Igari, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|July 9, 2013
What characteristics at baseline are associated with the glucose-lowering effect of colestimide in patients with type 2 diabetes and hypercholesterolemia according to response to treatment?Tatsuya Suzuki, Misako Tsunoda-Kubota, Junya Aoyama, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|February 16, 2010
The importance of assessment of endothelial function according to the time course of flow-mediated dilation of the brachial arteryKentaro Watanabe, Kenzo Oba, Tatsuya Suzuki, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|October 30, 2007
Colestimide lowers plasma glucose levels and increases plasma glucagon-like PEPTIDE-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemiaTatsuya Suzuki, Kenzo Oba, Yoshimasa Igari, et al.
Journal of Diabetes and Its Complications|January 14, 2012
Effects of bile-acid-binding resin (colestimide) on blood glucose and visceral fat in Japanese patients with type 2 diabetes mellitus and hypercholesterolemia: an open-label, randomized, case-control, crossover studyTatsuya Suzuki, Kenzo Oba, Yoshimasa Igari, et al.
Geriatrics & Gerontology International|September 29, 2011
Bile duct hamartomas (von Meyenburg complexes) associated with a bacterial infection: case report of elderly diabetic patientMasao Hashimoto, Motoshi Ouchi, Jun Norose, et al.
Clinical Biochemistry|June 20, 2013
Serum uric acid in relation to serum 1,5-anhydroglucitol levels in patients with and without type 2 diabetes mellitusMotoshi Ouchi, Kenzo Oba, Junya Aoyama, et al.
Journal of Pharmacological Sciences|May 5, 2022
Effects of 1,5-anhydro-D-glucitol on insulin secretion both in in vitro and ex vivo pancreatic preparationsMotoshi Ouchi, Asuka Morita, Keitaro Satoh, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 12, 2013
Change in urinary N-acetyl-β-d-glucosaminidase levels relevant to postprandial glycemic control conditions in subjects without diabetes mellitusMotoshi Ouchi, Kenzo Oba, Makoto Ohara, et al.
In Vivo (Athens, Greece)|August 19, 2021
The Effects of Trypsin Inhibitor on Insulin Secretion Using Rat Pancreas in an Organ BathAsuka Morita, Motoshi Ouchi, Keitaro Satoh, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Lipids in Health and Disease|March 19, 2013
Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: Lp(a) phenotype, lymphocyte, and coronary heart diseaseTatsuya Suzuki, Shoko Futami-Suda, Yoshimasa Igari, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|July 9, 2013
What characteristics at baseline are associated with the glucose-lowering effect of colestimide in patients with type 2 diabetes and hypercholesterolemia according to response to treatment?Tatsuya Suzuki, Misako Tsunoda-Kubota, Junya Aoyama, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|February 16, 2010
The importance of assessment of endothelial function according to the time course of flow-mediated dilation of the brachial arteryKentaro Watanabe, Kenzo Oba, Tatsuya Suzuki, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|October 30, 2007
Colestimide lowers plasma glucose levels and increases plasma glucagon-like PEPTIDE-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemiaTatsuya Suzuki, Kenzo Oba, Yoshimasa Igari, et al.
Journal of Diabetes and Its Complications|January 14, 2012
Effects of bile-acid-binding resin (colestimide) on blood glucose and visceral fat in Japanese patients with type 2 diabetes mellitus and hypercholesterolemia: an open-label, randomized, case-control, crossover studyTatsuya Suzuki, Kenzo Oba, Yoshimasa Igari, et al.
Geriatrics & Gerontology International|September 29, 2011
Bile duct hamartomas (von Meyenburg complexes) associated with a bacterial infection: case report of elderly diabetic patientMasao Hashimoto, Motoshi Ouchi, Jun Norose, et al.
Clinical Biochemistry|June 20, 2013
Serum uric acid in relation to serum 1,5-anhydroglucitol levels in patients with and without type 2 diabetes mellitusMotoshi Ouchi, Kenzo Oba, Junya Aoyama, et al.
Journal of Pharmacological Sciences|May 5, 2022
Effects of 1,5-anhydro-D-glucitol on insulin secretion both in in vitro and ex vivo pancreatic preparationsMotoshi Ouchi, Asuka Morita, Keitaro Satoh, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 12, 2013
Change in urinary N-acetyl-β-d-glucosaminidase levels relevant to postprandial glycemic control conditions in subjects without diabetes mellitusMotoshi Ouchi, Kenzo Oba, Makoto Ohara, et al.
In Vivo (Athens, Greece)|August 19, 2021
The Effects of Trypsin Inhibitor on Insulin Secretion Using Rat Pancreas in an Organ BathAsuka Morita, Motoshi Ouchi, Keitaro Satoh, et al.
Pageof 6